US2022396545A1PendingUtilityA1
Methods of making olefinic e- and z-isomers
Est. expiryMay 30, 2037(~10.8 yrs left)· nominal 20-yr term from priority
C07D 317/36C07C 67/31C07B 2200/09C07C 67/317C07C 67/333B01J 31/2217C07C 67/327C07C 67/343C07D 301/14B01J 2231/543
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Method of making a second olefm using a first olefin, comprising steps (A) and (B): (A) performing a metathesis reaction with the first olefm in the presence of a metal complex configured to catalyse said metathesis reaction; (B) epoxidizing an olefin contained in the reaction mixture obtained in step (A) to form an epoxide; and deoxygenizing said epoxide to form said second olefin.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A method of making a second olefin using a first olefin, comprising steps (A) and (B):
(A) performing a metathesis reaction with the first olefin in the presence of a metal complex configured to catalyse said metathesis reaction in order to obtain a reaction mixture containing an olefin; (B) epoxidizing the olefin contained in the reaction mixture obtained in step (A) to form an epoxide; and deoxygenizing said epoxide to form said second olefin; wherein step (A) comprises step (Al 1): (A11) subjecting the first olefin to a cross metathesis reaction with a fourth olefin in the presence of a metal complex to form a fifth olefin, wherein the metal complex is configured to favour the formation of the Z-isomer over the formation of the E-isomer of the fifth olefin; and further comprising the subsequent conversion of the Z-isomer into the E-isomer to form the second olefin, wherein step (B) comprises steps (B11) to (B14): (B11) epoxidizing said Z-isomer; (B12) subjecting the epoxide obtained in step (B11) to hydrolysis to form a diol or to alcoholysis to form a beta-hydroxy ether; (B13) converting the diol or beta-hydroxy ether obtained in step (B12) to a 1,3-dioxolane; (B14) degrading the 1,3-dioxolane obtained in step (B13) to form the second olefin in the form of its E-isomer.
22 . The method of claim 21 , wherein the fourth olefin is an internal olefin.
23 . The method of claim 22 , wherein the first and fourth olefin are identical.
24 . The method of claim 22 , wherein the first and the fourth olefin are different from one another.
25 . The method of claim 21 , wherein the fourth olefin is a terminal olefin.
26 . The method of claim 25 , wherein the first and the fourth olefin are identical.
27 . The method of claim 25 , wherein the first and the fourth olefin are different from one another.
28 . The method of claim 21 , wherein the first and the fourth olefin are methyl 9-decenoate of formula 3, respectively,
and the second olefin is methyl E-9-octadecenedioate of formula 4
29 . The method of claim 21 , wherein the metal complex is selected from a compound of formula (I):
wherein
M═Mo or W
X═O or N—R 5 ;
R 1 =H;
R 2 =CMe 3 ; CMe 2 Ph; or o-C1-6-alkoxyphenyl, optionally substituted;
R 3 =substituted aryloxy, preferably substituted phenyloxy, substituted naphthyl-2-oxy or substituted 5,6,7,8-tetrahydronaphthyl-2-oxy, or substituted naphthyl-1-oxy;
R 4 =pyrrol-1-yl, 2,5-dimethylpyrrol-1-yl; or 2,5-diphenylpyrrol-1-yl; or substituted or unsubstituted indol-1-yl;
R 5 =C 6-20 aryl or C 4-10 alkyl; optionally substituted. R z =neutral ligand;
n=0 or 1;
or
from a compound of formula (II):
wherein
M═Ru;
each of R 1 and L is a neutral ligand;
r=1-3;
each of R 4 and R 5 is independently bonded to M through sulfur or oxygen; or R 4 and
R 5 are halogen, preferably Cl;
R 14 is a carbene;
or
from a compound of formula (III):
wherein
Q is a hydrocarbylene, or alkyl-substituted hydrocarbylene;
Q* forms a carbon-ruthenium bond with the carbon from the R 3 group;
X 1 is nitrate, or C 1-20 alkylcarboxylate;
R 3 is cycloalkyl or an alkyl substituted cycloalkyl group;
R 4 is an alkyl substituted aryl group;
Z is alkyl; and
R 5 , R 6 , R 7 and R 8 are hydrogen.
30 . The method of claim 29 , wherein the catalyst is selected from
(Mes=mesityl; Cy=cyclohexyl; DIPP=diisopropyphenyl; TBS=tert.-butyldimethylsilyl; mes=mesitylene; Ad=1-adamantyl; Ph=phenyl; TMS=trimethylsilyl, Me=methyl; Pr=propyl).Join the waitlist — get patent alerts
Track US2022396545A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.